← Back to Clinical Trials
Recruiting NCT06602206

NCT06602206 Shoulder and Neck Mobilization in Patients With Subacromial Impingement Syndrome

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06602206
Status Recruiting
Phase
Sponsor Kutahya Health Sciences University
Condition Subacromial Impingement Syndrome
Study Type INTERVENTIONAL
Enrollment 45 participants
Start Date 2024-10-07
Primary Completion 2026-09

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Conventional Treatmentshoulder mobilizationneck mobilization

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 45 participants in total. It began in 2024-10-07 with a primary completion date of 2026-09.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Patients who come to Tavşanlı State Hospital's Physical Therapy and Rehabilitation Department and have been diagnosed with subacromial impingement syndrome by a physician will be included. Patients will be selected by randomization method among the patients determined by the physician to receive conservative treatment, shoulder mobilization in addition to conservative treatment, and neck mobilization treatment program in addition to these. Conventional treatments such as hot packs, TENS, ultrasound, and exercise will be given to all patients by the hospital staff. Pain intensity will be evaluated with VAS. Additionally, painful arch and pain-free joint range of motion evaluation will be made using a goniometer. The DASH questionnaire will be used to evaluate shoulder functionality. Sensory evaluation will be made with pressure pain threshold and two-point discrimination tests. Measurements will be made before the intervention and repeated after 3 weeks of intervention.

Eligibility Criteria

Inclusion Criteria: * Being over 18 years of age * Diagnosed with Subacromial Impingement * Not having received any treatment for shoulder problems in the last 6 months * The pain has been continuing for 3 months * Initial pain must be 4 or higher on the Visual Analog Scale (VAS) Exclusion Criteria: * History of surgery in the shoulder, cervical and thoracic region * Having a shoulder problem such as a frozen shoulder or instability * Full-thickness rotator cuff tear * Having systemic musculoskeletal disease * Having systemic rheumatic disease * History of upper extremity fracture * Diagnosed with scoliosis * Have neurological problems

Contact & Investigator

Central Contact

Meltem Işıntaş

✉ meltem.isintas@ksbu.edu.tr

📞 +902742652031

Principal Investigator

Meltem Işıntaş

STUDY DIRECTOR

Kutahya Health Sciences University

Frequently Asked Questions

Who can join the NCT06602206 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Subacromial Impingement Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06602206 currently recruiting?

Yes, NCT06602206 is actively recruiting participants. Contact the research team at meltem.isintas@ksbu.edu.tr for enrollment information.

Where is the NCT06602206 trial being conducted?

This trial is being conducted at Kütahya, Turkey (Türkiye).

Who is sponsoring the NCT06602206 clinical trial?

NCT06602206 is sponsored by Kutahya Health Sciences University. The principal investigator is Meltem Işıntaş at Kutahya Health Sciences University. The trial plans to enroll 45 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology